bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Jan. 15, 2023
Abstract
The
adult
healthy
human
pancreas
has
been
poorly
studied
given
lack
of
indication
to
obtain
tissue
from
the
in
absence
disease
and
rapid
postmortem
degradation.
We
obtained
pancreata
brain
dead
donors
thus
avoiding
any
warm
ischemia
time.
30
were
diverse
age
race
had
no
known
disease.
Histopathological
analysis
samples
revealed
PanIN
lesions
most
individuals
irrespective
age.
Using
a
combination
multiplex
immunohistochemistry,
single
cell
RNA
sequencing,
spatial
transcriptomics,
we
provide
first
ever
characterization
unique
microenvironment
sporadic
lesions.
compared
pancreatic
cancer
peritumoral
observed
distinct
transcriptomic
signatures
fibroblasts,
and,
lesser
extent,
macrophages.
epithelial
cells
remarkably
transcriptionally
similar
cells,
suggesting
that
neoplastic
pathways
are
initiated
early
tumorigenesis.
Statement
significance
causes
underlying
onset
remain
largely
unknown,
hampering
detection
prevention
strategies.
Here,
show
abundant
present
at
much
higher
rate
than
incidence
cancer,
setting
stage
for
efforts
elucidate
microenvironmental
intrinsic
factors
restrain,
or,
conversely,
promote,
malignant
progression.
Frontiers in Oncology,
Journal Year:
2025,
Volume and Issue:
15
Published: March 13, 2025
Pancreatic
ductal
adenocarcinoma
(PDAC)
is
a
leading
cause
of
cancer-related
mortality,
primarily
due
to
late
stage
at
diagnosis.
This
review
examines
the
multifaceted
applications
liquid
biopsy
and
circulating
tumor
DNA
(ctDNA)
analysis
in
diagnosis
management
PDAC.
We
current
literature
on
technological
advancements
such
as
next
generation
sequencing
(NGS)
digital
droplet
PCR
(ddPCR)
well
multi-omics
technologies,
highlighting
their
potential
for
accurate
molecular
subtyping
through
ctDNA
analysis.
highlights
significant
role
assessment
behavior,
disease
subtyping,
prediction
monitoring
treatment
response,
evaluation
minimal
residual
disease.
discuss
implications
integrating
techniques
into
clinical
practice
its
challenges
limitations.
By
drawing
insights
from
recent
studies,
this
aims
provide
comprehensive
overview
how
can
enhance
early
strategies
underscore
need
additional
prospective
studies
trials
validate
feasibility
accuracy
order
establish
utility,
with
ultimate
goal
routine
incorporation
improve
patient
outcomes
transform
landscape
Cancer Letters,
Journal Year:
2025,
Volume and Issue:
unknown, P. 217662 - 217662
Published: March 1, 2025
Pancreatic
ductal
adenocarcinoma
(PDAC)
is
one
of
the
deadliest
cancers,
with
a
5-year
survival
rate
only
12.5%.
Early
detection
PDAC
or
addressing
risk
factors
for
development
are
ways
to
improve
outcomes.
can
arise
from
precursor
lesions,
including
pancreatic
intraepithelial
neoplasia
(PanIN),
intraductal
papillary
mucinous
neoplasm
(IPMN),
and
less
frequent,
cystic
(MCN),
other
rare
variants.
High-risk
lesions
harbor
substantial
chance
evolving
into
PDAC.
Such
often
be
found
in
resected
specimens
adjacent
cancer.
Unfortunately,
recognizing
that
need
tricky,
resections
frequently
end
major
surgical
interventions.
Thus,
better
handle
desperately
needed.
We
mapped
immune
microenvironments
(IMEs)
PanINs,
IPMNs,
MCNs
on
cellular
level
using
multiplex
immunofluorescence
computational
imaging
technology
compared
findings
PDACs
normal
tissues.
distinct
potentially
targetable
mechanisms
immunosuppression
between
two
main
PanIN
IMPN.
Immunosuppression
IPMNs
seems
partly
mediated
by
programmed
cell
death
protein
1
ligand
(PD-L1)
expression
antigen-presenting
cells
(APCs).
By
contrast,
elevated
numbers
regulatory
T
(Tregs)
seem
key
players
PanINs.
treating
high-risk
anti-PD-1
PanINs
agents
targeting
Tregs,
such
as
anti-lymphocyte
associated
4
(anti-CTLA-4)
antibodies,
could
reverse
their
immunosuppressive
state.
Reversal
will
restore
immunosurveillance
eventually
prevent
progression
also
review
relevant
published
ongoing
non-surgical
treatment
approaches
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 14, 2025
Abstract
Image-based
machine
learning
tools
have
emerged
as
powerful
resources
for
analyzing
medical
images,
with
deep
learning-based
semantic
segmentation
commonly
utilized
to
enable
spatial
quantification
of
structures
in
images.
However,
customization
and
training
algorithms
requires
advanced
programming
skills
intricate
workflows,
limiting
their
accessibility
many
investigators.
Here,
we
present
a
protocol
software
automatic
images
guided
by
graphical
user
interface
(GUI)
using
the
CODAvision
algorithm.
This
workflow
simplifies
process
microanatomical
enabling
users
train
highly
customizable
models
without
extensive
coding
expertise.
The
outlines
best
practices
creating
robust
datasets,
configuring
model
parameters,
optimizing
performance
across
diverse
biomedical
image
modalities.
enhances
usability
CODA
algorithm
(
Nature
Methods
,
2022)
streamlining
parameter
configuration,
training,
evaluation,
automatically
generating
quantitative
results
comprehensive
reports.
We
expand
beyond
original
implementation
serial
histology
demonstrating
numerous
modalities
biological
questions.
provide
sample
data
types
including
histology,
magnetic
resonance
imaging
(MRI),
computed
tomography
(CT).
demonstrate
use
this
tool
applications
metastatic
burden
vivo
deconvolution
spot-based
transcriptomics
datasets.
is
designed
researchers
interest
rapid
design
basic
understanding
anatomy.
Cancers,
Journal Year:
2025,
Volume and Issue:
17(9), P. 1541 - 1541
Published: May 1, 2025
The
stroma
of
healthy
pancreases
contains
various
non-hematopoietic,
non-endothelial
mesenchymal
cells.
It
is
altered
by
chronic
inflammation
which
in
turn
a
major
contributor
to
the
development
pancreatic
adenocarcinoma
(PDAC).
In
PDAC,
plays
decisive
and
well-investigated
role
for
tumor
progression
therapy
response.
This
review
addresses
central
stromal
cells
early
inflammation-driven
PDAC.
focuses
on
subpopulations
cells,
i.e.,
fibroblasts,
stellate
multipotent
particularly
their
activation
functional
alterations
upon
including
different
types
carcinoma-associated
fibroblasts.
second
part,
current
knowledge
impact
activated
acinar-to-ductal
metaplasia
transition
intraepithelial
neoplasia
summarized.
Finally,
putative
strategies
target
signaling
carcinogenesis
are
reflected.
summary,
data
show
that
resulting
fibrotic
changes
has
pro-
anti-carcinogenetic
effects
but,
overall,
creates
carcinogenesis-promoting
microenvironment.
However,
this
dynamic
process
therapeutic
targeting
specific
pathways
requires
in-depth
molecular
interplay
cell
types.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 1, 2025
Pancreatic
ductal
adenocarcinoma
(PDAC)
is
characterized
by
a
complex
tumor
microenvironment
(TME)
including
stromal
cells
that
influence
resistance
to
therapy.
Recent
studies
have
revealed
cancer-associated
fibroblasts
(CAFs)
are
heterogeneous
in
origin,
gene
expression,
and
function.
Antigen-presenting
CAFs
(apCAFs),
defined
major
histocompatibility
(MHC)-II
expression
can
activate
effector
CD4
+
T
the
potential
contribute
anti-cancer
immune
response,
but
also
induce
regulatory
cell
(Treg)
differentiation.
Whether
apCAFs
promote
or
restrain
antitumor
response
remains
uncertain.
Using
clones
of
KPC
murine
PDAC
model
differing
sensitivity
checkpoint
blockade
(ICB),
we
found
immunosensitive
(sKPC)
tumors
were
higher
apCAF
infiltration
than
resistant
(rKPC)
tumors.
IMC
analysis
showed
proximity
both
sKPC
rKPC
implicating
interaction
within
TME.
apCAF-depleted
tumor-bearing
mice
had
diminished
ICB.
from
activated
tumor-infiltrating
induced
Treg
However,
transcriptomic
Tregs
overexpressed
for
immunosuppressive
genes
rKPCs
relative
sKPCs,
this
associated
with
differential
chemokine
signaling
depending
on
origin.
Together
these
data
implicate
as
important
mediators
modulation
which
could
facilitate
development
more
effective
anti-tumor
based
approaches
patients.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Dec. 6, 2023
Methods
for
spatially
resolved
cellular
profiling
using
thinly
cut
sections
have
enabled
in-depth
quantitative
tissue
mapping
to
study
inter-sample
and
intra-sample
differences
in
normal
human
anatomy
disease
onset
progression.
These
methods
often
profile
extremely
limited
regions,
which
may
impact
the
evaluation
of
heterogeneity
due
sub-sampling.
Here,
we
applied
CODA,
a
deep
learning-based
platform,
reconstruct
three-dimensional
(3D)
microanatomy
grossly
cancer-containing
pancreas
biospecimens
obtained
from
individuals
who
underwent
pancreatic
resection.
To
compare
inter-
heterogeneity,
assessed
bulk
composition
cohort
two-dimensional
(2D)
whole
slide
images
(WSIs)
thick
slabs
that
were
digitally
reconstructed
3D
serial
sections.
demonstrate
marked
under
sampling
2D
assessments,
simulated
number
WSIs
microarrays
(TMAs)
necessary
represent
compositional
data
within
10%
error
reveal
tens
hundreds
TMA
cores
are
sometimes
needed.
We
show
spatial
correlation
different
structures
decay
significantly
span
microns,
demonstrating
histological
not
be
representative
their
neighboring
tissues.
In
sum,
assessments
accurately
assess
abnormal
specimens
order
determine
neoplastic
content.
results
emphasize
importance
efforts.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Dec. 30, 2024
Molecular
imaging
using
positron
emission
tomography
(PET)
provides
sensitive
detection
and
mapping
of
molecular
targets.
While
cancer-associated
fibroblasts
integrins
have
been
proposed
as
targets
for
pancreatic
ductal
adenocarcinoma
(PDAC),
herein,
spatial
transcriptomics
proteomics
human
surgical
samples
are
applied
to
select
PDAC
We
find
that
selected
cancer
cell
surface
markers
spatially
correlated
provide
specific
localization,
whereas
the
correlation
between
immune-related
or
fibroblast
is
low.
Claudin-4
expression
increases
~16
fold
in
compared
with
normal
pancreas,
tight
junction
localization
confers
low
background
tissue.
develop
a
peptide-based
agent
targeted
claudin-4
accumulation
~25%
injected
activity
per
cubic
centimeter
(IA/cc)
metastases
~18%
IA/cc
tumors.
Our
work
motivates
data-driven
approach
selection
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 6, 2024
SUMMARY
Pancreatic
ductal
adenocarcinoma
(PDAC)
is
a
highly
lethal
cancer
for
which
few
effective
therapies
exist.
Immunotherapies
specifically
are
ineffective
in
pancreatic
cancer,
part
due
to
its
unique
stromal
and
immune
microenvironment.
intraepithelial
neoplasia,
or
PanIN,
the
main
precursor
lesion
PDAC.
Recently
it
was
discovered
that
PanINs
remarkably
abundant
grossly
normal
pancreas,
suggesting
vast
majority
will
never
progress
cancer.
Here,
through
construction
of
48
samples
cm
3
-sized
human
pancreas
tissue,
we
profiled
microenvironment
1,476
3D
at
single-cell
resolution
better
understand
early
evolution
tumor
determine
how
inflammation
may
play
role
progression.
We
found
bulk
strongly
correlates
PanIN
cell
fraction.
response
around
heterogeneous,
with
distinct
hotspots
cold
spots
appear
disappear
span
tens
microns.
Immune
generally
mark
locations
higher
grade
dysplasia
near
acinar
atrophy.
The
composition
these
dominated
by
naïve,
cytotoxic,
regulatory
T
cells,
associated
fibroblasts,
macrophages,
little
similarity
less-inflamed
PanINs.
By
mapping
FOXP3+
cells
3D,
present
density
larger
lesions
compared
smaller
PanINs,
initiation
not
exhibit
an
immunosuppressive
response.
This
analysis
demonstrates
while
common
pancreases
most
individuals,
pivotal
role,
both
microscopic
scale,
demarcating
regions
significance
Carcinogenesis,
Journal Year:
2024,
Volume and Issue:
45(11), P. 801 - 816
Published: Nov. 1, 2024
This
review
explores
the
progression
of
pancreatic
intraepithelial
neoplasia
(PanIN)
to
ductal
adenocarcinoma
through
a
dual
lens
intrinsic
molecular
alterations
and
extrinsic
microenvironmental
influences.
PanIN
development
begins
with
Kirsten
rat
sarcoma
viral
oncogene
(KRAS)
mutations
driving
initiation.
Key
additional
in
cyclin-dependent
kinase
inhibitor
2A
(CDKN2A),
tumor
protein
p53
(TP53),
mothers
against
decapentaplegic
homolog
4
(SMAD4)
disrupt
cell
cycle
control
genomic
stability,
crucial
for
from
low-grade
high-grade
dysplasia.
Additional
neoplastic
cells,
including
epigenetic
modifications
chromosomal
alterations,
can
further
contribute
progression.
In
parallel
these
microenvironment,
fibroblast
activation,
extracellular
matrix
remodeling,
immune
modulation,
plays
pivotal
role
initiation
Crosstalk
between
stromal
cells
influences
nutrient
support
evasion,
contributing
development,
growth,
survival.
underscores
intricate
interplay
cell-intrinsic
drivers
cell-extrinsic
factors,
shaping
predisposition,
initiation,
Future
research
aims
unravel
interactions
develop
targeted
therapeutic
strategies
early
detection
techniques,
aiming
alleviate
severe
impact
cancer
by
addressing
both
genetic
predispositions
environmental